Leaflet DETRUSITOL SR 4mg prolonged release capsules
Indicated for: overactive bladder; urinary incontinence
Route of administration: oral
Substance: tolterodine (urinary antimuscarinic)
ATC: G04BD07 (Genito urinary system and sex hormones | Urologicals | Drugs for urinary frequency and incontinence)
Use caution if you have glaucoma or increased eye pressure.
May cause dry mouth, constipation, urinary retention, or blurred vision.
Older people may have an increased risk of side effects.
Tolterodine is an antimuscarinic agent used in the treatment of overactive bladder, characterized by symptoms such as frequent urination, urinary urgency, and urinary incontinence. It works by blocking muscarinic receptors in the detrusor muscle of the bladder, reducing involuntary contractions and increasing bladder capacity.
Tolterodine is administered orally, usually once or twice daily, with the dose adjusted based on patient response and tolerability. It is available in immediate-release or extended-release tablet forms.
Common side effects include dry mouth, constipation, headache, and blurred vision. In rare cases, severe adverse reactions such as urinary retention or allergic reactions may occur. It is important for patients to follow the recommended dosage and inform their doctor of any side effects.
Tolterodine is an effective therapeutic option for managing overactive bladder symptoms, contributing to improved quality of life for patients.
General data about DETRUSITOL SR 4mg
- Substance: tolterodine
- Date of latest medicines list: 01-10-2014
- Product code: W52804001
- Concentration: 4mg
- Pharmaceutical form: prolonged release capsules
- Quantity: 28
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for tolterodine
Concentrations available for tolterodine
- 1mg
- 2mg
- 4mg